Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
IQ-AI Ltd LSE:IQAI London Ordinary Share JE00BD4H0R42 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.075p -5.17% 1.375p 1.35p 1.40p 1.45p 1.35p 1.45p 739,165 11:11:38
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Retailers 0.0 -0.3 -0.6 - 0.93

IQ-AI Ltd Share Discussion Threads

Showing 76 to 99 of 100 messages
Chat Pages: 4  3  2  1
DateSubjectAuthorDiscuss
10/2/2019
21:21
Not entirely what I'm saying because the IQAI board have been telling their shareholders that the FDA process is underway and has been for a long time now. I just had doubts about how they could get FDA approval for StoneChecker when the core TexRAD software running on it hadn't also applied for and gained FDA approval. They obviously think it can be done, whereas I am more sceptical. If StoneChecker can get FDA approval before TexRAD's very own FDA approval then what exactly are the FDA approving with StoneChecker? The theory but not the proof of concept? Sounds a little weird to me. If StoneChecker functionality is fully approved then what need is there for TexRAD's owners to have their own FDA approval later this year? And yet they have definitely said they will be applying for TexRAD FDA approval at some point after end May '19. I just find it all a bit puzzling.
lr2
10/2/2019
20:14
So IQAI are wasting time and money with their application for approval with the FDA because it wil have no chance and they should not have bothered until this September instead of last year,is that what you are saying?
hulk2004
09/2/2019
17:17
Oh thanks I haven't kept upto speed with this one lately.
hazl
09/2/2019
13:55
Nothing to do with the fact that TexRAD, the core software component in StoneChecker, isn't applying for FDA approval until at least June of this year then?
lr2
09/2/2019
13:09
Hardly their fault for the delay I would suggest... 'The UK's National Institute for Health and Care Excellence ("NICE") has issued a Medical Information Bulletin on IQ-AI's StoneChecker Software, having evaluated the clinical value and cost effectiveness of the product. The StoneChecker software's regulatory approval process continues in the USA. The recent and continuing threat of a USA Government shutdown has delayed the review of the product. However, the Company is in frequent contact with Food and Drug Administration ("FDA"), updating and amending the pending application to meet the FDA's requirements. '
hazl
09/2/2019
12:52
Hmm Schwab has outperform rating on healthcare...will it apply here,I wonder?
hazl
07/1/2019
18:41
Did well today and I didn't notice! Too caught up with various things.
hazl
02/1/2019
13:36
Hey 3.01% holding! Good news...hmm wonder if somethings afoot? Or he just likes us?
hazl
02/1/2019
13:03
Who is Michael Waddle? Omega Developments?
ged5
17/12/2018
20:57
https://uk.webfg.com/news/news-and-announcements/iq-ai-subsidiary-sees-tech-installed-at-important-tumour-centre--3643002.html
hazl
17/12/2018
13:37
Suggest it's just the bounce from last weeks oversold, which was ridiculous
jasonsd1970
17/12/2018
13:30
Interesting,indeed. f
fillipe
17/12/2018
13:24
Rises on no news.......interesting.
hazl
14/12/2018
14:47
Ah! A well deserved bounce . After all the CEO has a lot of 'skin in the game'. Often a good sign.
hazl
13/12/2018
10:37
My doubts about Brown's assertion of FDA clearance by year end were warranted. Now let's see if I'm also correct about the need for a placing in the next couple of months.
lr2
13/12/2018
08:11
It seems to me that the wheels go around a lot more slowly for FDA approval than events on the stock market......which can change at the blink of an eye! Will await further clarification in the new year.
hazl
13/12/2018
08:05
Ah another update.
hazl
11/12/2018
14:14
I can't believe I missed this RNS and so it appears has the market generally! Clearly lots going on in the background.
hazl
09/12/2018
19:29
LR2 agreed placing will come in 2019 just when and at what price! FDA approval has been touted on several occasions and all on track so will have to believe that.
hulk2004
09/12/2018
17:48
Hi Hulk, Brown does state the company is fully funded until June '19 in the half-year accounts but the accounts figures in that document suggest otherwise. Let's see if I am closer than Brown before money begins to run out. We will know that come end-February. Also, according to Brown, FDA clearance is expected by end of this month whereas I have some doubts when the TexRAD software integral to StoneChecker will not even be presented for FDA clearance until next June at the earliest. In fairness, people here tell me that FDA clearance is a simple self-certification procedure and that TexRAD not having clearance holds no sway over StoneChecker clearance. Still, I have trouble getting my head around that concept.
lr2
09/12/2018
16:39
Indeed hulk. So many little Aim medical companies fail to get noticed,yet IQAI is already getting contracts. Again, in S Korea, which is flourishing at the moment....very different to how it was a few years back. With regards BBSN I know what you mean,but I think cash in the bank does them credit so perhaps ok where it is for now,or make sure it's in dollars? IMO
hazl
09/12/2018
16:37
Bbsn which I also hold and they have 5million in cash but they have to do something with that cash in 2019 because cash is a negative on balance sheet if kept over a period of time because with inflation it’s a wasting asset! So will be happy for IQAI to raise funds to further 2 invested companies progress which appear to be all on track.
hulk2004
09/12/2018
16:32
Half year report in September states fully funded for at least 12 months, so June/July/August they could run out of cash,a placing will come but I think more likely in April 2019 with FDA approval and other contracts announced so will be raised at higher price in theory.With 90 percent of AIM companies placings are never to far away so IQAI are no different, they might receive some management fees from the 2 companies for a period of time to keep them going but the pay off with this type of investment is when they dispose of the invested companies. I held Tern which in some ways are similar to IQAI and they went from 3p to 57p! Do not think that will happen here but if all goes to plan we could see a exit of 1 business with 12-18 months and I hope share price will be considerably higher than 2.8p!
hulk2004
09/12/2018
15:20
....the above is obviously good for IQAI being gadolinium free.
hazl
Chat Pages: 4  3  2  1
Your Recent History
LSE
IQAI
IQ-AI Ltd
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190224 00:46:32